Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vinod Dagar

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Plos One|December 30, 2011
An 11p15 imprinting centre region 2 deletion in a family with Beckwith Wiedemann syndrome provides insights into imprinting control at CDKN1CElizabeth Algar, Vinod Dagar, Menka Sebaj, et al.
BMC Cancer|December 17, 2009
Rapid detection of SMARCB1 sequence variation using high resolution meltingVinod Dagar, Chung-Wo Chow, David M Ashley, et al.
Pathology|November 6, 2008
Rhabdoid tumour: a malignancy of early childhood with variable primary site, histology and clinical behaviourXiangru Wu, Vinod Dagar, Elizabeth Algar, et al.
Cancer Research|February 28, 2007
Paternally inherited submicroscopic duplication at 11p15.5 implicates insulin-like growth factor II in overgrowth and Wilms' tumorigenesisElizabeth M Algar, Luke St Heaps, Artur Darmanian, et al.
Plos One|February 18, 2009
Imprinted CDKN1C is a tumor suppressor in rhabdoid tumor and activated by restoration of SMARCB1 and histone deacetylase inhibitorsElizabeth M Algar, Andrea Muscat, Vinod Dagar, et al.
Clinical Epigenetics|September 1, 2018
Genetic variation affecting DNA methylation and the human imprinting disorder, Beckwith-Wiedemann syndromeVinod Dagar, Wendy Hutchison, Andrea Muscat, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Plos One|December 30, 2011
An 11p15 imprinting centre region 2 deletion in a family with Beckwith Wiedemann syndrome provides insights into imprinting control at CDKN1CElizabeth Algar, Vinod Dagar, Menka Sebaj, et al.
BMC Cancer|December 17, 2009
Rapid detection of SMARCB1 sequence variation using high resolution meltingVinod Dagar, Chung-Wo Chow, David M Ashley, et al.
Pathology|November 6, 2008
Rhabdoid tumour: a malignancy of early childhood with variable primary site, histology and clinical behaviourXiangru Wu, Vinod Dagar, Elizabeth Algar, et al.
Cancer Research|February 28, 2007
Paternally inherited submicroscopic duplication at 11p15.5 implicates insulin-like growth factor II in overgrowth and Wilms' tumorigenesisElizabeth M Algar, Luke St Heaps, Artur Darmanian, et al.
Plos One|February 18, 2009
Imprinted CDKN1C is a tumor suppressor in rhabdoid tumor and activated by restoration of SMARCB1 and histone deacetylase inhibitorsElizabeth M Algar, Andrea Muscat, Vinod Dagar, et al.
Clinical Epigenetics|September 1, 2018
Genetic variation affecting DNA methylation and the human imprinting disorder, Beckwith-Wiedemann syndromeVinod Dagar, Wendy Hutchison, Andrea Muscat, et al.
Pageof 1